Page last updated: 2024-08-24

cy 208-243 and le 300

cy 208-243 has been researched along with le 300 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abul Azm, Sel D; El Khawass, el S; El Sayed, O; Enzensperger, C; Lehmann, J; Robaa, D	1

Other Studies

1 other study(ies) available for cy 208-243 and le 300

Article	Year
Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists. Journal of medicinal chemistry, 2010, Mar-25, Volume: 53, Issue:6 Topics: Animals; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Cricetulus; Dopamine Antagonists; Humans; Indoles; Kinetics; Ligands; Models, Chemical; Molecular Structure; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5	2010

Article

Year

Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists.

Journal of medicinal chemistry, 2010, Mar-25, Volume: 53, Issue:6

Topics: Animals; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Cricetulus; Dopamine Antagonists; Humans; Indoles; Kinetics; Ligands; Models, Chemical; Molecular Structure; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5

2010